TPA
DXCM icon

Trivium Point Advisory’s DexCom DXCM Stock Holding History

Trivium Point Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,276
Closed -$286K – 357
2025
Q2 		$286K Sell
3,276
-179
-5% -$14K 0.03% 292
2025
Q1 		$236K Buy
3,455
+200
+6% +$16.3K 0.03% 313
2024
Q4 		$253K Sell
3,255
-37
-1% -$2.74K 0.03% 306
2024
Q3 		$239K Sell
3,292
-496
-13% -$40.7K 0.03% 306
2024
Q2 		$429K Sell
3,788
-71
-2% -$8.98K 0.06% 220
2024
Q1 		$535K Buy
3,859
+63
+2% +$7.92K 0.12% 153
2023
Q4 		$471K Buy
3,796
+53
+1% +$5.41K 0.11% 147
2023
Q3 		$340K Buy
3,743
+272
+8% +$30.7K 0.09% 159
2023
Q2 		$446K Sell
3,471
-12
-0.3% -$1.45K 0.12% 157
2023
Q1 		$405K Hold
3,483
– – 0.11% 157
2022
Q4 		$403K Sell
3,483
-448
-11% -$49.2K 0.12% 150
2022
Q3 		$374K Sell
3,931
-78
-2% -$6.61K 0.12% 153
2022
Q2 		$328K Sell
4,009
-39
-1% -$3.56K 0.1% 165
2022
Q1 		$516K Buy
4,048
+320
+9% +$35K 0.11% 170
2021
Q4 		$500K Sell
3,728
-24
-0.6% -$3.45K 0.1% 164
2021
Q3 		$506K Buy
3,752
+340
+10% +$42.9K 0.12% 152
2021
Q2 		$364K Buy
3,412
+396
+13% +$38K 0.09% 169
2021
Q1 		$271K Buy
3,016
+608
+25% +$57.1K 0.07% 176
2020
Q4 		$233K Buy
+2,408
New +$215K 0.07% 172

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trivium Point Advisory's DXCM Position: Q3 2025 in Review

Trivium Point Advisory sold out of DexCom (DXCM) in Q3 2025, closing a stake of 3,276 shares — an estimated $286K sold.

Trivium Point Advisory first reported a position in DXCM in Q4 2020 and held it in 19 quarters. The position peaked at $535K in Q1 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Trivium Point Advisory reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Trivium Point Advisory sold 3,276 DexCom shares in Q3 2025, an estimated $286K.
  • Trivium Point Advisory first reported a position in DexCom in Q4 2020 and held it in 19 quarters.
  • Trivium Point Advisory's DexCom position peaked at $535K in Q1 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Trivium Point Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.